Skip to content

Postconditioning in the Treatment of Acute ST-segment Elevation Myocardial Infarction

Postconditioning Used to Limit Final Infarct Size in Patients With Acute ST-segment Elevation Myocardial Infarction

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00507156
Acronym
POSTCON
Enrollment
200
Registered
2007-07-25
Start date
2007-07-31
Completion date
Unknown
Last updated
2016-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-segment Myocardial Infarction

Brief summary

Standard treatment of patients with acute ST-segment elevation myocardial infarction consist of acute re-opening of the occluded coronary artery (primary PCI). Despite successful treatment of the epicardial vessel reperfusion is sometimes inadequate leading to large final infarct sizes. This phenomenon is known as the reperfusion injury. Several animal studies have indicated that graded re-opening of the artery may limit tissue damage. Generally this is referred to as mechanical postconditioning. The study investigates the effect on final infarct size evaluated by magnetic resonance scan of postconditioning of ST-segment elevation myocardial infarctions. Mechanical postconditioning is performed by means of several balloon inflations in the injured vessel following its acute re-opening.

Detailed description

Please see above

Interventions

Acute re-opening of the occluded coronary artery

PROCEDUREMechanical postconditioning

Mechanical postconditioning with 4 cycles 30/30 sek balloon inflations

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients more than 18 years * STEMI \< 12 hours * TIMI 0-1 in infarct related artery

Exclusion criteria

* Multivessel disease (stenoses in non-infarct related arteries \>70%) * Cardiogenic shock * Left main occlusions * Lesions that cannot be treated with stents * Previous CABG * Pregnancy * Severe renal insufficiency * Previous extensive Q-wave infarction * LBBB

Design outcomes

Primary

MeasureTime frame
Final infarct size evaluated by MR3 month

Secondary

MeasureTime frame
MACE (death, re-infarction, TLR)1, 15 month
Stent thrombosis15 month

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026